Skip to main content
Clinical Trials/IRCT20170925036401N2
IRCT20170925036401N2Recruiting未知

Comparison of the efficacy of intracoronary and intravenous Eptifibatide and intracoronary Retaplase in thrombus aspiration in patients undergoing Primary percutaneous coronary interventions (PPCI); Randomized clinical trial study)

Deputy of Research of Guilan University of Medical Sciences0 sites160 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
160

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 80 years (—)
Sex
All

Inclusion Criteria

  • Ischemic typical chest pain extending more than 30 min;
  • ST elevation more than 1 mm in at least 2 leads with the same name;
  • all patients with STEMI candidate for primary PCI;
  • myocardial infarction not extending more than 12 hours;
  • having life expectancy not less than 6 months;
  • consent for participation in the study;
  • age 18 to 80 years;
  • no evidence for prior myocardial infarction;
  • not having contraindications for reteplase or eptifibatide;
  • not having left bundle branch block; not using GPIIb/IIIa in recent two weeks.

Exclusion Criteria

  • Rescue PCI after thrombolytic therapy;
  • emergency CABG;
  • cardiogenic shock;
  • TIMI flow grade 3 in primary angiography

Investigators

Sponsor
Deputy of Research of Guilan University of Medical Sciences

Similar Trials

effect of eptifibatide and reteplase on... | Clinical Trial